Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET Centre. The event offered a rich program—from tracer development to clinical applications in the nuclear medicine procedures, total‑body PET breakthroughs, and AI‑driven imaging strategies.
The dynamic exchange between seasoned experts, technologists, and early‑career researchers made it clear: innovation in nuclear medicine is accelerating.
Such forums go beyond technical curiosity: they are instrumental in shaping next‑generation diagnostics and refining trial design. Axcellant is energized by the practical insights gained and is already exploring how to integrate them into imaging‑based clinical research services.
We are committed to deepening our knowledge and strengthening our expertise in precision imaging, enabling us to continue delivering smarter, more effective trial solutions.
A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…
The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.…
What Are Nuclear Medicine Procedures and How Are They Used in Clinical Trials? Nuclear medicine procedures (NMPs) are diagnostic and/or…
Copyright @ 2025 Axcellant